Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Biopsy Renal Transplant With C4D Without IF

This test evaluates the health of a transplanted kidney, helping to detect potential rejection and assess graft function in kidney transplant recipients.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
A tissue sample (biopsy) from the transplanted kidney is required. Confirm specific collection procedures with the laboratory or your physician.
Results
Results are typically available within 5 days. Confirm with the laboratory before booking.
Preparation
No specific patient preparation is typically required for this test, but follow any instructions provided by your doctor or the transplant team.
Test priceKSh 13,500

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Biopsy Renal Transplant With C4D Without IF test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Monitoring kidney transplant recipients.
  • ✓Investigating decreased kidney function post-transplant.
  • ✓Evaluating potential transplant rejection.
  • ✓Assessing unexplained changes in kidney health after transplantation.
  • ✓Guiding immunosuppressive therapy adjustments.
02

In plain language

What this test helps you understand

This test helps monitor kidney transplant recipients for signs of rejection, assess the overall health of the transplanted kidney, and guide treatment decisions regarding immunosuppressive therapy.
The Biopsy Renal Transplant With C4D Without IF test is a diagnostic procedure used to assess the condition of a transplanted kidney. It is particularly important for individuals who have received a kidney transplant, as it helps identify early signs of rejection or other issues affecting the transplanted organ. This test involves examining a small tissue sample from the transplanted kidney under a microscope, using specific techniques to look for signs of damage or immune response. The C4D component specifically looks for evidence of antibody-mediated rejection. Understanding the health of the transplanted kidney is crucial for managing the patient's condition and adjusting treatment plans as needed.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is typically required for this test, but follow any instructions provided by your doctor or the transplant team.
SampleA tissue sample (biopsy) from the transplanted kidney is required. Confirm specific collection procedures with the laboratory or your physician.
MethodologyHistopathology and immunohistochemistry techniques are used to examine the kidney tissue sample for signs of rejection, including the presence of C4d.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test evaluates a specific sample of kidney tissue at a single point in time. Results may not reflect the entire kidney or future changes. Interpretation requires correlation with clinical findings and other laboratory tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

A kidney transplant biopsy involves taking a small sample of tissue from the transplanted kidney to examine it under a microscope. This helps doctors assess the health of the kidney.
The C4D component specifically looks for a protein called C4d, which is often present in cases of antibody-mediated rejection, a type of transplant rejection.
This test is primarily for individuals who have received a kidney transplant, especially if there are concerns about the kidney's function or potential rejection.
A pathologist interprets the biopsy results. Your doctor will discuss the findings with you, explaining what they mean for your health and treatment plan.
Yes, a doctor's prescription is required to perform this test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp